Clinical analysis of sentinel lymph node biopsy of 138 cases with breast cancer / 中国基层医药

Objective To investigate the clinical value of sentinel lymph node biopsy(SLNB)in breast cancer.Methods SLNB by using a 1% methylene blue 2mL subcutaneous was performed in 138 female patients with breast cancer,clinical stage Ⅰ,Ⅱ,stage,aged from 32 to 55 years old.Results Identification rate,accuracy rate, sensitivity,false negative rate of SLNB were 94.2%,96.0%,91.1% and 8.1%.Conclusion SLNB can conduct clinical axillary lymph node dissection narrow range,reduce the surgical trauma and postoperative complications.Ⅰ,Ⅱ sentinel lymph node -negative breast cancer patients may not have ipsilateral axillary dissection.